Fiera Capital (Canada)’s Ionis Pharmaceuticals IONS Stock Holding History

Fiera Capital (Canada)’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-492,213	Closed	-$25.4M	–	697
2018 Q3	$25.4M	Sell	492,213 -87,162	-15%	-$4.1M	0.1%	165
2018 Q2	$24.1M	Sell	579,375 -1,477	-0.3%	-$65.5K	0.1%	161
2018 Q1	$25.6M	Sell	580,852 -28,012	-5%	-$1.42M	0.12%	144
2017 Q4	$30.6M	Sell	608,864 -21,448	-3%	-$1.18M	0.15%	138
2017 Q3	$32M	Sell	630,312 -13,628	-2%	-$714K	0.15%	138
2017 Q2	$32.8M	Sell	643,940 -63,272	-9%	-$2.95M	0.16%	129
2017 Q1	$28.4M	Sell	707,212 -64,847	-8%	-$2.91M	0.15%	150
2016 Q4	$36.9M	Sell	772,059 -159,815	-17%	-$6.32M	0.21%	110
2016 Q3	$34.1M	Sell	931,874 -26,746	-3%	-$837K	0.19%	131
2016 Q2	$22.3M	Buy	+958,620	New	+$30.9M	0.13%	176
2016 Q1	–	Sell	-4,900	Closed	-$303K	–	589
2015 Q4	$303K	Buy	+4,900	New	+$264K	﹤0.01%	522

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Fiera Capital (Canada)'s IONS Position: Q4 2018 in Review

Fiera Capital (Canada) sold out of Ionis Pharmaceuticals (IONS) in Q4 2018, closing a stake of 492,213 shares — an estimated $25.4M sold.

Fiera Capital (Canada) first reported a position in IONS in Q4 2015 and held it in 11 quarters. The position peaked at $36.9M in Q4 2016. 330 funds tracked by Wall St. Rank hold IONS as of Q4 2018.

Fiera Capital (Canada) reported no remaining Ionis Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Fiera Capital (Canada) sold 492,213 Ionis Pharmaceuticals shares in Q4 2018, an estimated $25.4M.
Fiera Capital (Canada) first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 11 quarters.
Fiera Capital (Canada)'s Ionis Pharmaceuticals position peaked at $36.9M in Q4 2016.
330 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2018.

Based on Fiera Capital (Canada)'s 13F filing for Q4 2018, filed 12 Feb 2019.